• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Telehealth as Safe as Clinics for Abortion Pills, Study Finds

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 16, 2024.

By Dennis Thompson HealthDay Reporter

FRIDAY, Feb. 16, 2024 -- Medication abortion can be delivered safely and effectively using telemedicine, a large, new study concludes.

Women who received abortion pills through the mail following a video visit with a doctor fared just as well as women who visited a clinic, researchers report Feb. 15 in the journal Nature Medicine.

There were virtually no serious adverse events, with the medication proving safe 99.8% of the time, researchers found. Further, the women did not require follow-up care 98% of the time.

Those numbers are similar to the experience of patients who receive abortion pills following an in-person visit to a clinic or doctor’s office.

These findings come as the U.S. Supreme Court prepares to weigh whether the U.S. Food and Drug Administration acted correctly in broadening its policies to allow one commonly used abortion pill, mifepristone, to be prescribed through telehealth.

“This research confirms that the FDA followed science in allowing patients to get medication abortion through telehealth and the mail,” said lead researcher Ushma Upadhyay, a public health scientist with Advancing New Standards in Reproductive Health at the University of California, San Francisco.

“Our findings make it abundantly clear that the case at the Supreme Court is simply an attempt to restrict access to abortion care, even in those states where it’s legal,” Upadhyay added in a university news release.

Medication abortion now accounts for more than half of all abortions, researchers said in background notes.

It involves taking two pills, mifepristone followed by misoprostol.

Demand for the pills has skyrocketed since more than two dozen states banned or restricted abortion following the Supreme Court’s overturning of Roe v. Wade in June 2022, researchers said.

One U.S. online provider of the abortion pill combo saw a ten-fold jump in orders when news of the pending Roe v. Wade decision first leaked in 2022, according to a recent report in the journal JAMA Internal Medicine.

For the new study, researchers analyzed data from more than 6,000 patients who obtained abortion pills from virtual clinics in 20 states and Washington, D.C. between April 2021 and January 2022.

Researchers also compared video visits to secure text messaging and found that they were equally safe and effective.

They concluded that telehealth protects patient privacy while making abortion more accessible.

“Since the COVID-19 pandemic, telemedicine has become the new frontier in health care, including for medication abortion,” Upadhyay said. “A ruling against this method and the FDA’s rigorous science review process would be a huge blow to the American public and make this essential health service harder to get.”

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted February 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.